#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transferrin decreased Mycobacterium abscessus infection Pancreatic carcinoma Short-bowel syndrome Pulmonary arterial hypertension Acute graft versus host disease in intestine Dilated cardiomyopathy Autoinflammation with infantile enterocolitis Chronic granulomatous disease Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Glomerulonephritis membranoproliferative Breast angiosarcoma Gastroenteropancreatic neuroendocrine tumour disease Rosai-Dorfman syndrome Erythema multiforme More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Basic Information Loeys-Dietz syndrome – Diagnostics Choroid melanoma – Basic Information Lymphangiosarcoma – Trials in Disease Alternating hemiplegia of childhood Aicardi-Goutieres syndrome – Life with Disease Progressive supranuclear palsy – Trials in Disease Hepatoblastoma – Diagnostics Von Willebrand’s disease Von Willebrand’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Maralixibat Chloride Evencaleucel Tulisokibart CLESROVIMAB Pirtobrutinib Pyridoxine Omp12 D5-Ethyl-Beta-D-Glucuronide Pasireotide Diaspartate Mercaptopurine Monohydrate Etoricoxib Tulmimetostat Talazoparib Cefepime Hydrochloride Selgantolimod Tasimelteon Resmetirom Rbl016.2 Glucose, Anhydrous Clavulanic Acid More therapies…

    Learn about Your Condition

    Systemic infection Pharyngeal cancer stage II Ulcerative keratitis Amyotrophic lateral sclerosis Nodal osteoarthritis Hyperthyroidism Cerebral palsy Fracture infection Small intestine carcinoma Behcet's syndrome Partial seizures Head and neck cancer stage III Deafness Palpitations Pancreatic carcinoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Study on the Diagnostic Performance of 68Ga-ABS011 PET/CT for Patients with Metastatic Breast Cancer

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Neoplasm malignant
    Investigated Drugs:
    • 68Ga-Nota-Abscint-Her2
    Austria Belgium

  • Study on Blood Flow in the Vaginal Area After Total Laparoscopic Hysterectomy Using Indocyanine Green for Patients Undergoing Hysterectomy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hysterectomy
    Investigated Drugs:
    • Indocyanine Green
    France

  • Study Comparing [68Ga]Ga-PentixaFor PET/CT and AVS for Diagnosing Primary Aldosteronism in Patients with Hypertension

    Recruiting

    4 1 1
    Investigated Diseases:
    • Primary hyperaldosteronism
    Investigated Drugs:
    • Pentixafor
    • Gallium (68Ga)
    The Netherlands

  • Study on the Use of Fludeoxyglucose (18F) in PET/CT Scans for Young Patients with Histiocytosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Erdheim-Chester disease
    • Langerhans cell sarcoma
    • Rosai-Dorfman syndrome
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    Poland

  • Study on Improving Cervical Dysplasia Diagnosis in Postmenopausal Women Using Estradiol

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cervical dysplasia
    Investigated Drugs:
    • Estradiol
    Denmark

  • Study on Rocuronium Bromide for Neuromuscular Block in Infants with Craniosynostosis During Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Craniosynostosis
    Investigated Drugs:
    • Rocuronium Bromide
    Hungary
Previous Page
1 … 3 4 5 6 7 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!